Categories AlphaGraphs, Earnings, Health Care
Key highlights from Biogen’s (BIIB) Q1 2022 earnings results
Biogen Inc. (NASDAQ: BIIB) reported first quarter 2022 earnings results today.
Total revenue decreased 6% year-over-year to $2.53 billion.
GAAP net income attributable to Biogen Inc. was $304 million, or $2.06 per share, compared to $410 million, or $2.69 per share, last year. Adjusted EPS amounted to $3.62.
For full-year 2022, total revenue is estimated to be $9.7-10 billion while adjusted EPS is expected to be $14.25-16.00.
Prior performance
Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!
Most Popular
Infographic: How Lennar (LEN) performed in Q4 2025
Lennar Corporation (NYSE: LEN) reported total revenues of $9.4 billion for the fourth quarter of 2025, compared to $9.9 billion reported in the same period a year ago. Net earnings
Paychex expected to report higher revenue and earnings for Q2 FY26
Paychex, Inc. (NASDAQ: PAYX), a leading provider of human capital management solutions, is undergoing an AI-driven transformation that enhances both its internal operations and client-facing services. Entering fiscal 2026, the
Signet Jewelers (SIG): A look at the progress made on Grow Brand Love
Shares of Signet Jewelers Limited (NYSE: SIG) fell over 3% on Tuesday. The stock has gained 3% year-to-date. The jewelry retailer delivered strong results for the third quarter of 2026,
